Truist Reiterates Buy Rating on Nuvation Bio Inc (NUVB) as 'Ibtrozi Momentum Builds'
Tweet Send to a Friend
Truist Securities analyst Greg Renza reiterated a Buy rating and $12.00 price target on Nuvation Bio Inc (NYSE: NUVB).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
